$0.643
-0.0072 (-1.11%)
At Close: Jul 31, 2026
Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome
08:30am, Wednesday, 11'th Mar 2026
— Fast Track Designation facilitates development and expedites regulatory review of therapies addressing serious conditions with significant unmet medical need —
NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therap
Cabral Gold Provides Update on Construction Progress at Cuiú Cuiú; Project on Track for Q4 2026 Production
07:02am, Thursday, 05'th Mar 2026
Vancouver, British Columbia--(Newsfile Corp. - March 5, 2026) - Cabral Gold Inc. (TSXV: CBR) (OTCQX: CBGZF) ("Cabral" or the "Company") is pleased to provide a construction update regarding its Phas
Johnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus erythematosus (SLE)
08:03am, Tuesday, 03'rd Mar 2026
Fast Track designation reflects the unmet need in this serious disease and enables the potential for an accelerated FDA review timeline The designation is supported by a Phase 2 study in which nipoca
Archer Announces Fourth Quarter and Full Year 2025 Results, US and UAE Air Taxi Pilot Programs On-Track for 2026
04:05pm, Monday, 02'nd Mar 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $ACHR #Archer--Archer Aviation Inc. (“Archer” or the “Company”) (NYSE: ACHR) today announced operating and financial results for the fourth quarter and
UroGen Announces ZUSDURI™ Launch is On-Track and Reports Fourth Quarter and Full Year 2025 Financial Results
08:00am, Monday, 02'nd Mar 2026
Commercial launch is on-track for ZUSDURI™, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC); net sal
Aktis Oncology Receives U.S. FDA Fast Track Designation for AKY-1189, a Nectin-4 Miniprotein Radioconjugate
08:00am, Tuesday, 24'th Feb 2026
BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to larg
7 Ways The Train Could Go Off The Track For Nvidia
11:03am, Monday, 23'rd Feb 2026
7 Ways The Train Could Go Off The Track For Nvidia
Bonterra Energy: Growth Strategy On Track
09:42am, Monday, 23'rd Feb 2026
Bonterra Energy acquires more Charlie Lake acreage. The recent Charlie Lake acquisition enables production growth with fewer wells. Transitioning toward liquids production enhances profitability.
3 Standout ETFs With a Proven Track Record of Success
07:13am, Monday, 23'rd Feb 2026
The world of exchange-traded funds (ETFs) expands and changes at a rapid pace, with investors funneling more than a trillion dollars into these products annually amid a host of new fund launches. It c
Financial Survey: SecureAlert (OTCMKTS:TRCK) vs. SoundHound AI (NASDAQ:SOUN)
01:46am, Sunday, 22'nd Feb 2026
SoundHound AI (NASDAQ: SOUN - Get Free Report) and SecureAlert (OTCMKTS:TRCK - Get Free Report) are both computer and technology companies, but which is the superior business? We will compare the two
OMAH: Berkshire Hathaway Covered Call Income ETF, Strong Distribution Yield, Short Track Record
11:06pm, Saturday, 21'st Feb 2026
OMAH's equity portfolio mirrors Berkshire Hathaway's top holdings, plus direct BRK exposure. Income is boosted with covered calls, resulting in a 14.3% distribution yield. Upside potential is limited.
Financial Institutions, Inc.: Back On Track After A Challenging Year
03:55pm, Friday, 20'th Feb 2026
Financial Institutions, Inc. rebounded after a challenging 2024 marked by restructuring and significant losses. The company's return on assets reached 1.27% in Q4 2025, and return on equity came in at
CLOB: Diversified CLO ETF With Quality Holdings, Strong Yield, And Track Record
01:13pm, Friday, 20'th Feb 2026
CLOB: Diversified CLO ETF With Quality Holdings, Strong Yield, And Track Record
Sign In
Buy TRCK